Acta Cardiologica Sinica最新文献

筛选
英文 中文
LncRNA H19: A Novel Biomarker in Cardiovascular Disease. LncRNA H19:心血管疾病的新型生物标记物
IF 1.9 4区 医学
Acta Cardiologica Sinica Pub Date : 2024-03-01 DOI: 10.6515/ACS.202403_40(2).20230925A
Xiaojun Li, Yugui Zhang, Zhaoran Ding, Yijun Chen, Wei Wang
{"title":"LncRNA H19: A Novel Biomarker in Cardiovascular Disease.","authors":"Xiaojun Li, Yugui Zhang, Zhaoran Ding, Yijun Chen, Wei Wang","doi":"10.6515/ACS.202403_40(2).20230925A","DOIUrl":"10.6515/ACS.202403_40(2).20230925A","url":null,"abstract":"<p><p>Cardiovascular disease is a major cause of death and disability worldwide. Recently, increasing evidence has demonstrated that long non-coding RNAs (lncRNAs) play critical roles in the pathogenesis of cardiovascular diseases, including atherosclerosis, coronary artery disease, dilated cardiomyopathy, diabetic cardiomyopathy, aortic dissection, and more. LncRNA H19 was the first to be described as a non-protein-coding mRNA-like molecule. A large number of studies have found that lncRNA H19 is related to the pathophysiological processes of cardiovascular diseases, and it is emerging as a potential key regulator of various heart diseases. In this review, we aim to summarize the role of lncRNA H19 in cardiovascular diseases in order to provide a theoretical basis for its potential use as a new therapeutic target in the future.</p>","PeriodicalId":6957,"journal":{"name":"Acta Cardiologica Sinica","volume":"40 2","pages":"172-181"},"PeriodicalIF":1.9,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10961637/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140292462","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
2024 Guidelines of the Taiwan Society of Cardiology for the Diagnosis and Treatment of Heart Failure with Preserved Ejection Fraction. 2024 年台湾心脏病学会《射血分数保留型心力衰竭诊断与治疗指南》。
IF 1.9 4区 医学
Acta Cardiologica Sinica Pub Date : 2024-03-01 DOI: 10.6515/ACS.202403_40(2).20240206A
Yi-Heng Li, Chun-Chieh Wang, Chung-Lieh Hung, Yen-Wen Wu, Chih-Hsin Hsu, Yi-Liang Tsou, Chao-Hung Wang, Cho-Kai Wu, Po-Lin Lin, Hung-Yu Chang, Shih-Hsien Sung, Zheng-Wei Chen, Jyh-Ming Jimmy Juang, Tzung-Dau Wang, Wen-Jone Chen
{"title":"2024 Guidelines of the Taiwan Society of Cardiology for the Diagnosis and Treatment of Heart Failure with Preserved Ejection Fraction.","authors":"Yi-Heng Li, Chun-Chieh Wang, Chung-Lieh Hung, Yen-Wen Wu, Chih-Hsin Hsu, Yi-Liang Tsou, Chao-Hung Wang, Cho-Kai Wu, Po-Lin Lin, Hung-Yu Chang, Shih-Hsien Sung, Zheng-Wei Chen, Jyh-Ming Jimmy Juang, Tzung-Dau Wang, Wen-Jone Chen","doi":"10.6515/ACS.202403_40(2).20240206A","DOIUrl":"10.6515/ACS.202403_40(2).20240206A","url":null,"abstract":"<p><p>Heart failure with preserved ejection fraction (HFpEF) is a multi-organ systemic syndrome that involves cardiac and extra-cardiac pathophysiological abnormalities. Its growing prevalence causes a major public concern worldwide. HFpEF is usually associated with multiple comorbidities, and non-cardiovascular death is common in patients with HFpEF. In Asia, patients with HFpEF has a younger age, higher prevalence of diabetes and chronic kidney disease than Western countries. A 2-step diagnostic algorithm is recommended in this guideline. In the first step, the diagnosis of HFpEF can be made if patients have symptoms and/or signs of heart failure, left ventricular ejection fraction ≥ 50%, increased natriuretic peptide, and objective evidence of left atrial or left ventricular abnormalities or raised left ventricular filling pressure. If diagnosis is still uncertain, invasive or noninvasive stress test can be performed in the second step. Comorbidities need to be controlled in HFpEF. Weight reduction for obesity and supervised exercise training are recommended for HFpEF. For pharmacological therapy, diuretic is used to relieve congestion and sodium-glucose cotransporter 2 inhibitor, empagliflozin or dapagliflozin, is recommended to improve prognosis of HFpEF. The research on HFpEF is advancing at a rapid pace. It is expected that newer modalities for diagnosis and management of HFpEF could appear in the near future.</p>","PeriodicalId":6957,"journal":{"name":"Acta Cardiologica Sinica","volume":"40 2","pages":"148-171"},"PeriodicalIF":1.9,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10961629/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140292455","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of Glidesheath Slender and Subcutaneous Nitrate Administration in Terms of Radial Artery Complications: A Retrospective Single-Center Experience. 从桡动脉并发症的角度比较 Glidesheath Slender 和皮下注射硝酸酯:回顾性单中心经验
IF 1.9 4区 医学
Acta Cardiologica Sinica Pub Date : 2024-03-01 DOI: 10.6515/ACS.202403_40(2).20231127A
Kürşat Akbuğa, Aksüyek Savaş Çelebi
{"title":"Comparison of Glidesheath Slender and Subcutaneous Nitrate Administration in Terms of Radial Artery Complications: A Retrospective Single-Center Experience.","authors":"Kürşat Akbuğa, Aksüyek Savaş Çelebi","doi":"10.6515/ACS.202403_40(2).20231127A","DOIUrl":"10.6515/ACS.202403_40(2).20231127A","url":null,"abstract":"<p><strong>Objectives: </strong>The transradial route is used in most coronary procedures today. Although this method seems to be advantageous in terms of bleeding complications and patient comfort, the small radial artery diameter brings with it complications such as radial artery spasm and occlusion. It has been demonstrated in previous studies that subcutaneous nitrate administration dilates the radial artery. The Glidesheath Slender, which has a thinner outer wall than conventional sheaths, is another method that has been shown to reduce complications by reducing friction on the radial artery wall. Our aim was to compare these two methods in terms of complications.</p><p><strong>Methods: </strong>We retrospectively reviewed patients with complete clinical and radial Doppler ultrasound records who had undergone transradial interventions. We compared procedures using subcutaneous nitrate application plus conventional sheaths with procedures using the Glidesheath Slender sheath in terms of procedural and post-procedural complications.</p><p><strong>Results: </strong>Eighty-seven patients in the subcutaneous nitrate group and 35 patients in the Glidesheath Slender group were included in the study. There were no significant differences between the two groups in terms of procedural and postprocedural complications (p = 0.511 and p = 0.333, respectively).</p><p><strong>Conclusions: </strong>In cases where a thin-walled sheath such as a Glidesheath Slender is not available, subcutaneous nitrate administration seems to be similar, especially in terms of preventing radial artery spasm.</p>","PeriodicalId":6957,"journal":{"name":"Acta Cardiologica Sinica","volume":"40 2","pages":"208-213"},"PeriodicalIF":1.9,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10961635/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140292457","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Incidence and Predictors of Acute Coronary Syndrome in Patients on Maintenance Hemodialysis: A Prospective Cohort Study. 维持性血液透析患者急性冠状动脉综合征的发病率和预测因素:前瞻性队列研究
IF 1.9 4区 医学
Acta Cardiologica Sinica Pub Date : 2024-03-01 DOI: 10.6515/ACS.202403_40(2).20231022A
Ju-Yin Hsu, Chih-Kuo Lee, Shou-Yung Chaung, Chi-Hung Cheng, Li-Pei Dai, Mu-Yang Hsieh, Chung-Wei Yang, Chih-Cheng Wu
{"title":"Incidence and Predictors of Acute Coronary Syndrome in Patients on Maintenance Hemodialysis: A Prospective Cohort Study.","authors":"Ju-Yin Hsu, Chih-Kuo Lee, Shou-Yung Chaung, Chi-Hung Cheng, Li-Pei Dai, Mu-Yang Hsieh, Chung-Wei Yang, Chih-Cheng Wu","doi":"10.6515/ACS.202403_40(2).20231022A","DOIUrl":"10.6515/ACS.202403_40(2).20231022A","url":null,"abstract":"<p><strong>Background: </strong>Cardiovascular diseases are the leading cause of death among patients on hemodialysis, with approximately 40% of the cardiovascular deaths linked to acute coronary syndrome. We aimed to investigate the incidence and risk factors of acute coronary syndrome in patients undergoing hemodialysis.</p><p><strong>Methods: </strong>Patients undergoing hemodialysis were prospectively enrolled from January 2018. Data regarding hospitalization due to acute coronary syndrome were collected at 3-month intervals through December 31, 2021. Cox regression model was used to estimate the association between baseline factors and incident acute coronary syndrome during follow-up.</p><p><strong>Results: </strong>Patients' mean age was 66 years, 48% were men, and 16% had a history of coronary artery disease at enrolment. Over a median follow-up of 1,187 days, 85 patients were hospitalized due to acute coronary syndrome. Left main or triple vessel disease was identified in 67 patients. Risk factors associated with incident acute coronary syndrome included aging, male sex, smoking, low diastolic blood pressure, and baseline comorbidities, in addition to dialysis factors including low urea clearance, central venous catheter use, and history of dialysis access dysfunction. After multivariate analysis, age, diabetes, hyperlipidemia, smoking, and frequent interventions for vascular access remained significant risk factors.</p><p><strong>Conclusions: </strong>A high acute coronary syndrome incidence was observed in our cohort, with traditional risk factors playing a consistent role with that in the general population. A history of frequent dialysis access dysfunction was also associated with incident acute coronary syndrome.</p>","PeriodicalId":6957,"journal":{"name":"Acta Cardiologica Sinica","volume":"40 2","pages":"191-199"},"PeriodicalIF":1.9,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10961640/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140292460","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Acute Effect in Mechanical Efficiency by Pressure-Volume Loop Analysis after Transcatheter Aortic Valve Implantation. 经导管主动脉瓣植入术后压力-容积环路分析对机械效率的急性影响
IF 1.9 4区 医学
Acta Cardiologica Sinica Pub Date : 2024-03-01 DOI: 10.6515/ACS.202403_40(2).20231230A
Shen-Che Lin, Chih-Yao Chiang, Jung-Cheng Hsu, Jih-Hsin Huang, Jer-Shen Chen, Kuan-Ming Chiu
{"title":"Acute Effect in Mechanical Efficiency by Pressure-Volume Loop Analysis after Transcatheter Aortic Valve Implantation.","authors":"Shen-Che Lin, Chih-Yao Chiang, Jung-Cheng Hsu, Jih-Hsin Huang, Jer-Shen Chen, Kuan-Ming Chiu","doi":"10.6515/ACS.202403_40(2).20231230A","DOIUrl":"10.6515/ACS.202403_40(2).20231230A","url":null,"abstract":"<p><strong>Background: </strong>This study aimed to evaluate the immediate effect of transcatheter aortic valve implantation (TAVI) on mechanical efficiency.</p><p><strong>Methods: </strong>A total of 46 patients (25 females) with an average age of 83 ± 6.4 years underwent TAVI using the CoreValve system. During the same hospitalization, we conducted a comprehensive comparison of the patients before and after TAVI without inotropic support using echocardiography. The parameters encompassed left ventricular (LV) geometry, valvular load, global LV afterload and ventricular hemodynamics. The analysis using pressure-volume loops enabled the determination of load-independent contractility (Ees) and afterload, in addition to assessing potential energy, stroke work, and mechanical efficiency.</p><p><strong>Results: </strong>The immediate effect was an augmented aortic valve area accompanied by a reduction in the transvalvular pressure gradient. We observed reductions in left ventricular end-systolic volume and end-diastolic volume, and also reductions in global afterload and end-systolic meridional wall stress. The Ea index decreased, while the Ees index remained relatively stable. We noted increases in stroke volume and systemic arterial compliance, indicating more efficient blood transfer from the ventricle to aorta. These changes contributed to the normalization of ventricular-arterial coupling. In terms of mechanical work of the chamber, we observed significant decreases in potential energy, stroke work, and pressure-volume area. There was an increase in the mechanical efficiency of the chamber.</p><p><strong>Conclusions: </strong>The TAVI procedure immediately reduced global afterload and improved diastolic compliance of the chamber, resulting in enhanced ventricular function and mechanical efficiency.</p>","PeriodicalId":6957,"journal":{"name":"Acta Cardiologica Sinica","volume":"40 2","pages":"242-252"},"PeriodicalIF":1.9,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10961641/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140292456","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Heart Failure with Preserved Ejection Fraction: It's Time to Act. 射血分数保留型心力衰竭:是时候行动了
IF 1.8 4区 医学
Acta Cardiologica Sinica Pub Date : 2024-03-01 DOI: 10.6515/ACS.202403_40(2).20240207A
Yi-Heng Li
{"title":"Heart Failure with Preserved Ejection Fraction: It's Time to Act.","authors":"Yi-Heng Li","doi":"10.6515/ACS.202403_40(2).20240207A","DOIUrl":"10.6515/ACS.202403_40(2).20240207A","url":null,"abstract":"","PeriodicalId":6957,"journal":{"name":"Acta Cardiologica Sinica","volume":"40 2","pages":"147"},"PeriodicalIF":1.8,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10961633/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140292459","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Risks and Benefits of Continuing Renin-Angiotensin-Aldosterone System Inhibitors in Critically-Ill Patients. 重症患者继续使用肾素-血管紧张素-醛固酮系统抑制剂的风险和益处。
IF 1.9 4区 医学
Acta Cardiologica Sinica Pub Date : 2024-03-01 DOI: 10.6515/ACS.202403_40(2).20231206B
Ruey-Hsing Chou, Shang-Feng Yang, Po-Hsun Huang
{"title":"Risks and Benefits of Continuing Renin-Angiotensin-Aldosterone System Inhibitors in Critically-Ill Patients.","authors":"Ruey-Hsing Chou, Shang-Feng Yang, Po-Hsun Huang","doi":"10.6515/ACS.202403_40(2).20231206B","DOIUrl":"10.6515/ACS.202403_40(2).20231206B","url":null,"abstract":"","PeriodicalId":6957,"journal":{"name":"Acta Cardiologica Sinica","volume":"40 2","pages":"260-261"},"PeriodicalIF":1.9,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10961638/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140292463","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Taiwan Society of Cardiology Heart Failure Registry 2020: Rationale and Design. 台湾心脏病学会心力衰竭注册 2020:原理与设计。
IF 1.9 4区 医学
Acta Cardiologica Sinica Pub Date : 2024-03-01 DOI: 10.6515/ACS.202403_40(2).20230822A
Hung-Yu Chang, Chi-Ming Lee, Chung-Lieh Hung, Shih-Hsien Sung, Tsung-Hsien Lin, Yen-Wen Wu, Juey-Jen Hwang, Wen-Jone Chen, Chun-Chieh Wang
{"title":"Taiwan Society of Cardiology Heart Failure Registry 2020: Rationale and Design.","authors":"Hung-Yu Chang, Chi-Ming Lee, Chung-Lieh Hung, Shih-Hsien Sung, Tsung-Hsien Lin, Yen-Wen Wu, Juey-Jen Hwang, Wen-Jone Chen, Chun-Chieh Wang","doi":"10.6515/ACS.202403_40(2).20230822A","DOIUrl":"10.6515/ACS.202403_40(2).20230822A","url":null,"abstract":"<p><strong>Background: </strong>Heart failure (HF) is a significant public health problem worldwide. Death and rehospitalization rates are similar across different HF phenotypes. However, the existing Taiwanese HF registries mainly enrolled inpatients with HF and reduced ejection fraction (HFrEF) before 2019, so their results may not apply to outpatients or patients with HF with mildly reduced ejection fraction (HFmrEF) and HF with preserved ejection fraction (HFpEF) phenotypes.</p><p><strong>Methods: </strong>The Taiwan Society of Cardiology Heart Failure Registry 2020 is a prospective, multicenter, observational registry that will enroll patients with HF from 27 hospitals in Taiwan between 2020 and 2022 and will be followed for two years. Patients eligible for enrollment include those admitted due to acute decompensated heart failure or outpatients with a history of hospitalization for heart failure within the past six months. The registry will collect patient demographics, medical history, HF diagnosis, medication use, examination results, and comorbidities. The registry plans to enroll 3,370 patients, with the distribution of HFrEF/HFmrEF/HFpEF as 59%/13%/28%. Follow-up intervals will occur every six months for up to two years to monitor clinical outcomes and major cardiac interventions. The registry will conclude in December 2024.</p><p><strong>Conclusions: </strong>The Taiwan Society of Cardiology Heart Failure Registry 2020 is a comprehensive and meticulous effort to demonstrate the epidemiology, adherence to guidelines, clinical outcomes, and disease progression of Taiwanese patients with HF in contemporary clinical practice.</p>","PeriodicalId":6957,"journal":{"name":"Acta Cardiologica Sinica","volume":"40 2","pages":"235-241"},"PeriodicalIF":1.9,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10961632/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140292466","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Impact of Intravenous Ferric Carboxymaltose on Reverse Electrical Remodeling Following Cardiac Resynchronization Therapy. 静脉注射羧甲基铁对心脏再同步化疗法后反向电重塑的影响
IF 1.9 4区 医学
Acta Cardiologica Sinica Pub Date : 2024-03-01 DOI: 10.6515/ACS.202403_40(2).20230828B
Evin Bozcali, Veli Polat
{"title":"The Impact of Intravenous Ferric Carboxymaltose on Reverse Electrical Remodeling Following Cardiac Resynchronization Therapy.","authors":"Evin Bozcali, Veli Polat","doi":"10.6515/ACS.202403_40(2).20230828B","DOIUrl":"10.6515/ACS.202403_40(2).20230828B","url":null,"abstract":"<p><strong>Background: </strong>The influence of intravenous ferric carboxymaltose (FCM) on reverse electrical remodeling (RER) in patients with heart failure with reduced ejection fraction (HFrEF) post-cardiac resynchronization therapy (CRT) is unknown. This study examines the effect of iron replacement using intravenous FCM on RER in CRT-implanted HFrEF patients with iron deficiency anemia.</p><p><strong>Methods: </strong>We retrospectively analyzed 65 patients with successful CRT-defibrillator between March 2017 and January 2020, all with iron deficiency anemia at implantation. The cohort comprised 35 patients in the FCM group and 30 in the non-FCM group. Follow-up data were obtained from visits 6 months post-CRT implantation including baseline characteristics, echocardiographic left ventricular measurements, and electrocardiograms. Changes in intrinsic QRS duration (iQRS) and left ventricular ejection fraction (LVEF) from baseline to 6 months were assessed.</p><p><strong>Results: </strong>The FCM group showed a greater reduction in iQRS duration compared to the non-FCM group (-10.4 ± 2.2 ms vs. -3 ± 2.9 ms, p < 0.0001). Additionally, at the 6-month follow-up, the increase in LVEF was higher in the FCM group than in the non-FCM group (+3.6 ± 1.6% vs. -0.1 ± 1.7%, p < 0.0001). Correlations were found between changes in ferritin levels and iQRS duration (r = -0.725, p < 0.0001) and LVEF (r = 0.712, p < 0.0001). Multivariate regression analysis revealed that elevated ferritin independently influenced the increase in LVEF (p = 0.006, β = 0.554) and the decrease in iQRS (p < 0.001, β = -0.685).</p><p><strong>Conclusions: </strong>Intravenous iron treatment with FCM may reduce iQRS duration and improve LVEF and functional status in HFrEF patients with iron deficiency anemia following CRT.</p>","PeriodicalId":6957,"journal":{"name":"Acta Cardiologica Sinica","volume":"40 2","pages":"182-190"},"PeriodicalIF":1.9,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10961630/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140292467","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Guidewire Fracture and Stent Shrinkage during Coronary Angiography. 冠状动脉造影过程中的导丝断裂和支架收缩。
IF 1.9 4区 医学
Acta Cardiologica Sinica Pub Date : 2024-03-01 DOI: 10.6515/ACS.202403_40(2).20231127B
Murat Özmen
{"title":"Guidewire Fracture and Stent Shrinkage during Coronary Angiography.","authors":"Murat Özmen","doi":"10.6515/ACS.202403_40(2).20231127B","DOIUrl":"10.6515/ACS.202403_40(2).20231127B","url":null,"abstract":"","PeriodicalId":6957,"journal":{"name":"Acta Cardiologica Sinica","volume":"40 2","pages":"253-257"},"PeriodicalIF":1.9,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10961636/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140292458","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信